Therapy Class Overview: Rituximab biosimilar PR Newswire UK (press release) In this report, we have analyzed the market opportunity of rituximab biosimilar. Key Topics Covered: 1. Executive Summary 2.Ex-US Experience of Biosimilar launch 3.Introduction - Rituxan/ MabThera (rituximab) 4.Opportunities and Threats for Rituximab ... |
